Inventor · disambiguated record
Michael Rigby
Also filed as: RIGBY MICHAEL
5 granted patents·11 pending applications·48 citations·filing 2006–2025
80Inventor score
Top patents by PatentIndex Score
16 records- 0196US11912792B2Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2022·Granted Feb 27, 2024·14 cites·18 claims
- 0296US11453702B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2021·Granted Sep 27, 2022·16 cites·21 claims
- 0396US11180531B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2019·Granted Nov 23, 2021·18 cites·24 claims
- 0489US12459974B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2024·Granted Nov 4, 2025·0 cites·11 claims
- 0588US2024400616A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 0684US2025263438A9Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 0784US2025051392A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 0876US2024391959A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 0973US2021269480A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2019·Application pending·0 cites
- 1071US2025340595A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2025·Application pending·0 cites
- 1166US11970555B2Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)BICYCLETX LTD·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 1259US2024382605A1Conjugated oligonucleotides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1352US2024173422A1Bicyclic peptide ligand drug conjugatesBICYCLETX LTD·Filed 2020·Application pending·0 cites
- 1451US2023233698A1Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular receptor a2 (epha2)BICYCLETX LTD·Filed 2021·Application pending·0 cites
- 1548US2009163544A1Use of NK-3 Receptor Antagonists for the Treatment of Nausea and VomitingRIGBY MICHAEL·Filed 2006·Application pending·0 cites
- 1648US2023181749A1Bicyclic peptide ligands specific for nectin-4 and uses thereofBICYCLE TX LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Rigby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →